Authors: Sun|, Roger(1,2,3,4)*[roger.sun@gustaveroussy.fr];Sundahl|, Nora(5);Hecht|, Markus(6);Putz|, Florian(6);Lancia|, Andrea(7);Milic|, Marina(3);Carré|, Alexandre(2,3);Lerousseau|, Marvin(2,3,4);Theo|, Estienne(2,3,4);Battistella|, Enzo(2,3,4);Alvarez Andres|, Emilie(2,3,4,8);Louvel|, Guillaume(1);Durand-Labrunie|, Jérôme(1);Bockel|, Sophie(1);Bahleda|, Rastislav(9);Robert|, Charlotte(2,3);Boutros|, Céline(10);Vakalopoulou|, Maria(4);Paragios|, Nikos(8);Frey|, Benjamin(6);Massard|, Christophe(11);Fietkau|, Rainer(6);Ost|, Piet(5);Gaipl|, Udo(6);Deutsch|, Eric(1,3);
(1)Gustave Roussy - Paris-Saclay University, Department of Radiation Oncology, Villejuif, France;(2)Gustave Roussy - Paris-Saclay University, Department of Medical Physics, Villejuif, France;(3)Paris-Sud University - Gustave Roussy - Inserm - Paris-Saclay University, U1030 Molecular Radiotherapy, Villejuif, France;(4)CentraleSupélec - Paris-Saclay University, Mathématiques et Informatique pour la Complexité et les Systèmes, Gif-sur-Yvette, France;(5)Ghent university hopital, Department of Radiation Oncology and Experimental Cancer Research, Gent, Belgium;(6)Universitätsklinikum Erlangen- Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Radiation Oncology, Erlangen, Germany;(7)Fondazione IRCCS- Policlinico San Matteo, Department of Radiation Oncology, Pavia, Italy;(8)TheraPanacea, Radiotherapy, Paris, France;(9)Gustave Roussy - Paris Saclay University, Drug Development Department, Villejuif, France;(10)Gustave Roussy - Paris Saclay University, Department of Medicine, Villejuif, France;(11)Gustave Roussy, Drug Development Department, Villejuif, France;
Show Affiliations
Hide Affiliations